Oregovomab

From WikiProjectMed
Jump to navigation Jump to search
Oregovomab
Monoclonal antibody
TypeWhole antibody
SourceMouse
TargetCA125
Clinical data
Trade namesOvaRex
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
Molar massca. 150 kg/mol
 ☒NcheckY (what is this?)  (verify)

Oregovomab (marketed under the trade name OvaRex) is a mouse monoclonal antibody it binds to the antigen CA125, a carbohydrate antigen. It is designed for the treatment of ovarian cancer.[1]

This drug was developed by AltaRex Corp.

Adverse drug effects

References